Press release
Emerging Prostate Cancer Diagnostics Market Trends: Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market Shaping the Future of the Industry
Prostate Cancer Diagnostics
Prostate Cancer Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The market size for prostate cancer diagnostics has seen a swift expansion in the past few years. The market, valued at $4.43 billion in 2024, is projected to reach $5.03 billion in 2025, marking a compound annual growth rate (CAGR) of 13.6%. This growth over the historical period can be credited to factors such as the rising elderly population, progress in medical imaging, growing awareness and screening programs, initiatives related to public health and enhancements in biopsy methods.
How Will the Prostate Cancer Diagnostics Market Size Evolve and Grow by 2029?
The market size for prostate cancer diagnostics is projected to witness swift expansion in the coming years. The market is set to reach a valuation of $8.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth during the forecast period include the adoption of artificial intelligence (AI) strategies, the expansion of telemedicine in cancer detection, improvements in genomic profiling, patient-focused tactics, and the use of multiparametric MRI for diagnosing. Key trends anticipated in the forecast timeframe comprise liquid biopsy technologies, advances in biomarker detection technology, clinical studies and developments, the integration of digital pathology, and the rise of multiplex biomarker assays.
View the full report here:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
What Drivers Are Propelling the Growth of Prostate Cancer Diagnostics Market Forward?
The rise in cases of prostate cancer is anticipated to fuel the expansion of the market for prostate cancer diagnostics. Prostate cancer involves the growth of cancerous cells in the prostate gland, a part of both male and female reproductive systems. Diagnostics for prostate cancer allows early detection of the disease through a variety of tests such as prostate-specific antigen (PSA) testing and advanced imaging methods. In January 2023, the American Cancer Society (ACS) - a nonprofit organization in the U.S. dedicated to fighting cancer - reported approximately 288,300 new instances of prostate cancer and 34,700 deaths due to prostate cancer in 2023. Hence, the escalating cases of prostate cancer are likely to drive the expansion of the prostate cancer diagnostics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12003&type=smp
Which Emerging Trends Are Transforming the Prostate Cancer Diagnostics Market in 2025?
Technological advancements are becoming an increasingly prominent trend in the prostate cancer diagnostics market. In an effort to solidify their market standing, several prominent companies are opting for the development and introduction of progressive AI-driven tools custom-made for prostate cancer diagnosis. Notably, Qritive, a firm based in Singapore that specializes in the creation of diagnostic tools, launched its top-edge AI-driven tool, QAi Prostate, for prostate cancer diagnosis in March 2023. Geared towards pathologists, this tool makes use of sophisticated machine learning algorithms to locate the prostatic adenocarcinoma region and thoroughly analyse the whole slide images from prostate core needle biopsies. Through the usage of this tool, pathologists can ensure accurate and swift diagnoses, thereby greatly reducing treatment timelines.
What Are the Key Segments in the Prostate Cancer Diagnostics Market?
The prostate cancer diagnostics market covered in this report is segmented -
1) By Products: Instruments, Reagents And Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Pediatric, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Biopsy Instruments, Imaging Devices, Digital Rectal Examination Tools
2) By Reagents And Consumables: Diagnostic Assay Kits, Staining Reagents, Sample Collection Materials
3) By Accessories: Biopsy Guides, Specimen Handling Accessories, Calibration And Maintenance Tools
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12003&type=smp
Who Are the Key Players Shaping the Prostate Cancer Diagnostics Market's Competitive Landscape?
Major companies operating in the prostate cancer diagnostics market include F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton dic*kinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Dana-Farber Cancer Institute, Cellanyx Diagnostics Inc., A3P Biomedical AB
What Geographic Markets Are Powering Growth in the Prostate Cancer Diagnostics Market?
North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12003
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Prostate Cancer Diagnostics Market Trends: Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market Shaping the Future of the Industry here
News-ID: 4100400 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
Future Perspectives: Key Trends Shaping the Supply Chain Digital Twin Market Unt …
The supply chain digital twin market is gaining significant attention as companies look to improve operational efficiency and resilience through advanced technologies. This market is set to experience substantial growth in the coming years, driven by increasing digital transformation initiatives and the need for more agile supply chain management. Let's delve into the market's size, key players, driving trends, and segmentation to understand the future outlook.
Projected Market Size and Growth…
Leading Companies Reinforce Their Roles in the Stem Cell Therapy Market for Mult …
The field of stem cell therapy for multiple sclerosis is rapidly advancing, offering new hope for patients affected by this challenging neurological condition. As research and technology evolve, the market for these innovative treatments is expected to grow substantially. This overview explores the market size, key players, emerging trends, and segmentation of the stem cell therapy landscape for multiple sclerosis.
Projected Market Size and Growth Outlook for Stem Cell Therapy for…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
